Expression profiling of matrix metalloproteinase-9 and its inhibitors, TIMP-1 and reck, is associated with prognosis in prostate cancer (2010)
- Authors:
- USP affiliated authors: SILVA, IBANEZ ANDRADE - FSP ; DALL'OGLIO, MARCOS FRANCISCO - FM ; SROUGI, MIGUEL - FM
- Unidades: FSP; FM
- Subjects: METALOPROTEINASES; PROGNÓSTICO; NEOPLASIAS PROSTÁTICAS; MATRIZ EXTRACELULAR; RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP"
-
ABNT
REIS, S T et al. Expression profiling of matrix metalloproteinase-9 and its inhibitors, TIMP-1 and reck, is associated with prognosis in prostate cancer. Clinics. São Paulo: Faculdade de Saúde Pública, Universidade de São Paulo. . Acesso em: 12 maio 2024. , 2010 -
APA
Reis, S. T., Pontes Jr., J., Sousa-Carnavez, J. M., Silva, I. A., Antunes, A. A., Dall'Oglio, M. F., et al. (2010). Expression profiling of matrix metalloproteinase-9 and its inhibitors, TIMP-1 and reck, is associated with prognosis in prostate cancer. Clinics. São Paulo: Faculdade de Saúde Pública, Universidade de São Paulo. -
NLM
Reis ST, Pontes Jr. J, Sousa-Carnavez JM, Silva IA, Antunes AA, Dall'Oglio MF, Timoszczuk LMS, Nesrallah AA, Sant'Anna AC, Srougi M, Leite KRM. Expression profiling of matrix metalloproteinase-9 and its inhibitors, TIMP-1 and reck, is associated with prognosis in prostate cancer. Clinics. 2010 ; 65 S53.[citado 2024 maio 12 ] -
Vancouver
Reis ST, Pontes Jr. J, Sousa-Carnavez JM, Silva IA, Antunes AA, Dall'Oglio MF, Timoszczuk LMS, Nesrallah AA, Sant'Anna AC, Srougi M, Leite KRM. Expression profiling of matrix metalloproteinase-9 and its inhibitors, TIMP-1 and reck, is associated with prognosis in prostate cancer. Clinics. 2010 ; 65 S53.[citado 2024 maio 12 ] - Underrexpression of MIR-143, MIR-145 are related to high-risk localized prostate cancer
- MicroRNA-100 Expression is Independently Related to Biochemical Recurrence of Prostate Cancer
- Estratégia terapêutica em hiperplasia prostática benigna
- Hiperplasia prostática benigna (HPB): aspectos morfológicos e fisiopatológicos
- GREB1 tissue expression is associated with organ-confined prostate cancer
- Tratamento minimamente invasivo da hiperplásia prostática
- Laser em hiperplasia prostática benigna
- Significant heterogeneity in terms of diagnosis and treatment of renal cell carcinoma at a private and public hospital in Brazil
- miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer
- Interleukin-8 gene expression and prognosis in bladder cancer
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
